Because of the complexity of their cases, immunocompromised patients such as individuals with cancer often have been excluded from antimicrobial stewardship programs (ASPs) and studies. But the limited amount of research available suggests that such programs can effectively reduce antibiotic consumption and improve outcomes (Ann Pharmacother 2020;54[6]:594-610).
Building on the findings, investigators from Henry Ford Health System and Wayne State University, in Detroit, examined